<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03185754</url>
  </required_header>
  <id_info>
    <org_study_id>201212107RIND</org_study_id>
    <nct_id>NCT03185754</nct_id>
  </id_info>
  <brief_title>Comparison of Sublobar Resection and Lobectomy to Treat Lung Cancer</brief_title>
  <official_title>Comparison of Sublobar Resection and Lobectomy to Treat Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multi-center prospective randomized trial in Taiwan to investigate whether sublobar
      resection, as compared to lobectomy, can offer equivalent clinical results to treat early
      non-small cell lung cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Lung cancer has become an important disease threatening the public health
      world-wide. Surgical resection is the standard of care for treating non-small cell lung
      cancer in early stage. For decades, pulmonary lobectomy with lymph node dissection remains
      the gold standard of surgical approach. Pulmonary sublobar resection with pulmonary wedge
      resection or segmentectomy was reserved for the patients with high surgical risk, who were
      unsuitable for radical surgical resection. Pulmonary sublobar resection for tumor less than
      three centimeter was demonstrated to associated with higher risk of tumor recurrence or
      worsening survival outcome as compared to that done by lobectomy. 1 However, these data was
      which was not necessarily applicable to patients with early lung cancer with tumor of smaller
      size which was more frequently detected with the health screening test by CT scan in general
      population now. Although several retrospective studies has demonstrated that sublobar
      resection can offer a similar survival outcome after surgery as compared to that done by
      standard lobectomy once the tumor was smaller than two centimeter 2, there is still no
      consensus about the role of sublobar resection for these small early lung cancer. In general,
      there are several factors associating with higher risk of local recurrence which should be
      avoided for sublobar resection, including resection margin less than 2 cm or less than the
      diameter of the tumor itself 3, more obvious speculation in CT image or central location
      which makes it difficult to obtain adequate resection margin 4,5. Therefore, sublobar
      resection should be applied to the patients of early lung cancer when two cm of resection
      margin is achievable. The central location , obvious tumor infiltration in image study or
      presence of lymph node metastasis should be also avoided.

      Patients and methods: The study will include surgical patients from six medical centers in
      Taiwan. All of the patients will receive complete study about the surgical risk and tumor
      staging before surgery. The patients will receive general anesthesia and pulmonary resection
      as the standard procedures including division of pulmonary vessels and bronchus. Either VATS
      (Video-assisted thoracoscopic surgery) or open surgery is acceptable for the surgical
      approaches. The patients will be randomly assigned to lobectomy and sublobar resection
      groups. Two cm of resection margin will be obtained in each patient in the sublobar resection
      group by wedge resection or segmentectomy. Standard lymph node dissection including the
      pulmonary hilum and mediastinum will be done in both groups of patients. For suspicious of
      pulmonary hilum or mediastinal lymph node metastasis, frozen pathological examination will be
      requested.

      Post operative care and follow-up: The patients will be transferred to intensive care unit or
      surgical recovery room after surgery. Medication for pain control and postoperative
      rehabilitation education will be given to each patient after surgery. The chest tube will be
      removed after daily discharge less than 100 to 200 ml without air-leakage, adequate lung
      expansion noted in chest X ray imaging. The patient will be discharged from the hospital one
      or two days after removal of the chest tube. Whole body bone scan and CT scan will be given
      in every 6 months at least after surgery for postoperative follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 12, 2013</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease-free survival (DFS)</measure>
    <time_frame>5 years</time_frame>
    <description>The time interval from randomization to the earliest onset of any of the following events: tumor local recurrence, distant metastasis, and mortality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>post-operative complication</measure>
    <time_frame>3 months</time_frame>
    <description>defined as any deviation from the normal postoperative course</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization time</measure>
    <time_frame>3 months</time_frame>
    <description>the time interval from the day of surgery to discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chest tube duration</measure>
    <time_frame>3 months</time_frame>
    <description>the time interval from the day of surgery to the day of chest tube removal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post-operative pulmonary function</measure>
    <time_frame>6, 12 and 24 months</time_frame>
    <description>the pulmonary function at 6, 12, and 24 months post-operation</description>
  </secondary_outcome>
  <other_outcome>
    <measure>pain score</measure>
    <time_frame>1, 3, and 7 days</time_frame>
    <description>post-operative pain assessment during hospital stay</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>early phase lung cancer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sublobar resection and lobectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sublobar resection</intervention_name>
    <description>Sublobar resection</description>
    <arm_group_label>early phase lung cancer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>lobectomy</intervention_name>
    <description>lobectomy</description>
    <arm_group_label>early phase lung cancer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Early non-small cell lung cancer (stage Ia) with diameter of two centimeters or less.

          -  Tumor locating at the peripheral lung parenchyma (outer one third in CT imaging).

          -  No suspected hilar or mediastinal lymph nodes metastasis in the CT or PET imaging
             study.

        Exclusion criteria:

          -  Tumor diameter more than 2 centimeter

          -  Hilar or mediastinal lymphnode metastasis by the cancer.

          -  Patients received previous surgery in the ipsi-lateral lung

          -  Lung tumor locating in the central lung parenchyma unable to obtain curative resection
             by sublobar resection.

          -  Patients with poor cardiopulmonary function unsuitable for receiving surgical
             resection.

          -  Patients who have multiple lung cancer or other suspicious lesion in the lung.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lee Jang-Ming</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jang-Ming Lee</last_name>
      <phone>02-23123456</phone>
      <phone_ext>65123</phone_ext>
      <email>jangming@ntuh.gov.tw</email>
    </contact>
    <contact_backup>
      <last_name>Pei-Weng Yang</last_name>
      <phone>02-23123456</phone>
      <phone_ext>65071</phone_ext>
      <email>jmlee@ntu.edu.tw</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <results_reference>
    <citation>Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995 Sep;60(3):615-22; discussion 622-3.</citation>
    <PMID>7677489</PMID>
  </results_reference>
  <results_reference>
    <citation>Sienel W, Dango S, Kirschbaum A, Cucuruz B, HÃ¶rth W, Stremmel C, Passlick B. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections. Eur J Cardiothorac Surg. 2008 Apr;33(4):728-34. doi: 10.1016/j.ejcts.2007.12.048. Epub 2008 Feb 7.</citation>
    <PMID>18261918</PMID>
  </results_reference>
  <results_reference>
    <citation>Kodama K, Doi O, Higashiyama M, Yokouchi H. Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg. 1997 Sep;114(3):347-53.</citation>
    <PMID>9305186</PMID>
  </results_reference>
  <results_reference>
    <citation>Okada M, Yoshikawa K, Hatta T, Tsubota N. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller? Ann Thorac Surg. 2001 Mar;71(3):956-60; discussion 961.</citation>
    <PMID>11269480</PMID>
  </results_reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 13, 2013</study_first_submitted>
  <study_first_submitted_qc>June 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2017</study_first_posted>
  <last_update_submitted>June 19, 2017</last_update_submitted>
  <last_update_submitted_qc>June 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lung cancer</keyword>
  <keyword>surgery</keyword>
  <keyword>lobectomy</keyword>
  <keyword>sublobar resection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

